에 대한 최신 뉴스 Kindly MD (NASDAQ:KDLY) 주식

Kindly MD

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

Kindly MD Inc

Sun Life Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLF#NYSE">SLF</a>) reported quarterly earnings of $1.68 per share which missed the analyst consensus estimate of $1.79 by 6.15 percent. This is a 36.59 percent increase over earnings of $1.23 per share from the same period last year.

Earnings

Earnings Misses

News

Sun Life Financial Q4 2024 Adj EPS C$1.68 Misses C$1.79 Estimate

Fastly, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSLY#NYSE">FSLY</a>) reported its fourth-quarter financial results after Wednesday's closing bell. Here's a look at the <a href="http://Fastly Announces Fourth Quarter and Full Year 2024 Financial Results">details from the report. </a>
The Details: The San Francisco-based company reported quarterly losses of 3 cents per share. That&#8217;s down from earnings of 1 cent in the prior year&#8217;s quarter. Quarterly revenue came in at $140.58 million, beating the $138.27 million analyst consensus estimate.
<ul>
<li>Network services revenue was $427.7 million, representing 6% year-over-year growth. </li>
<li>Security revenue was $103 million, representing 11% year-over-year growth. </li>
<li>Other revenue was $12.9 million, representing 61% year-over-year growth.&nbsp;</li>
<li>Enterprise customer count was 596 in the fourth quarter, up 20 from the third quarter of 2024.</li>
<li>Fastly&#8217;s top ten customers accounted for 32% of revenue in the fourth quarter compared to 40% in the fourth quarter of 2023.</li>
</ul>
Read Next: <a href="https://www.benzinga.com/25/02/43667841/inflation-is-hot-and-getting-hotter">Inflation Runs Hot In January: &#8216;Houston We Have A Problem,&#8217; Experts Warn</a>&nbsp;
"We are pleased to report record fourth quarter revenue, exceeding the high-end of our guidance range," said Todd Nightingale, CEO of Fastly.
"Our platform strategy is delivering an accelerated innovation velocity and faster time to value for anyone building web experiences," continued Nightingale. &#8220;We enter 2025 with a strengthened balance sheet, a motivated go-to-market team, and intense focus on efficient customer acquisition and long-term revenue growth."
Outlook:&nbsp;Fastly expects first-quarter losses of between 9 cents and 5 cents per share, versus the loss of 1 cent estimate, and revenue in a range of $136 million to $140 million, versus the $137.05 million estimate. 
FSLY Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Fastly shares are down 18.57% after hours at $8.20 Wednesday.  
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/social-media/25/02/43535256/palantir-adds-elon-musks-ai-chatbot-grok-to-aip">Palantir Adds Elon Musk&#8217;s AI Chatbot Grok To AIP</a></li>
</ul>
Image: Shutterstock

Movers

Tech

FSLY

Fastly Shares Tumble After Q4 Report, Weak Forward Guidance

Scorpio Tankers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STNG#NYSE">STNG</a>) reported quarterly earnings of $0.63 per share which missed the analyst consensus estimate of $1.01 by 37.62 percent. This is a 77.09 percent decrease over earnings of $2.75 per share from the same period last year. The company reported quarterly sales of $203.97 million which missed the analyst consensus estimate of $222.39 million by 8.28 percent. This is a 39.35 percent decrease over sales of $336.31 million the same period last year.

STNG

Scorpio Tankers Q4 2024 Adj EPS $0.63 Misses $1.01 Estimate, Sales $203.97M Miss $222.39M Estimate

Kinross Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KGC#NYSE">KGC</a>) reported quarterly earnings of $0.20 per share which missed the analyst consensus estimate of $0.25 by 20 percent. This is a 81.82 percent increase over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $1.15 billion which missed the analyst consensus estimate of $1.47 billion by 21.86 percent. This is a 2.69 percent increase over sales of $1.12 billion the same period last year.

Kinross Gold Q4 2024 Adj EPS $0.20 Misses $0.25 Estimate, Sales $1.15B Miss $1.47B Estimate

SolarWinds (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWI#NYSE">SWI</a>) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.27 by 88.89 percent. This is a 112.5 percent increase over earnings of $0.24 per share from the same period last year. The company reported quarterly sales of $210.31 million which beat the analyst consensus estimate of $202.95 million by 3.63 percent. This is a 6.14 percent increase over sales of $198.14 million the same period last year.

Earnings Beats

SolarWinds Q4 2024 Adj EPS $0.51 Beats $0.27 Estimate, Sales $210.31M Beat $202.95M Estimate

MKS Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>) is looking for Q1 GAAP EPS of $0.35-$0.91 vs $1.07 analyst estimate..

Guidance

MKSI

MKS Instruments Sees Q1 GAAP EPS $0.35-$0.91 vs $1.07 Est

MKS Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>) is looking for Q1 Adj EPS of $1.13-$1.67 vs $1.62 analyst estimate. sees sales of $870.000 million-$950.000 million vs $908.69 million analyst estimate.

MKS Instruments Sees Q1 Adj EPS $1.13-$1.67 vs $1.62 Est; Sees Sales $870.000M-$950.000M vs $908.69M Est

MKS Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>) reported quarterly earnings of $2.15 per share which beat the analyst consensus estimate of $1.95 by 10.26 percent. This is a 83.76 percent increase over earnings of $1.17 per share from the same period last year. The company reported quarterly sales of $935.00 million which beat the analyst consensus estimate of $914.18 million by 2.28 percent. This is a 4.70 percent increase over sales of $893.00 million the same period last year.

MKS Instruments Q4 Adj $2.15 Beats $1.95 Estimate, Sales $935.00M Beat $914.18M Estimate

WIIM

Kadant shares are trading lower. The company reported Q4 financial results,

Oportun Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRT#NASDAQ">OPRT</a>) sees Q1 sales of $225.000 million-$230.000 million vs $249.78 million analyst estimate.

OPRT

Oportun Financial Sees Q1 Sales $225.000M-$230.000M vs $249.78M Est

Oportun Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRT#NASDAQ">OPRT</a>) is looking for FY2025 Adj EPS of $1.10-$1.30 vs $1.00 analyst estimate. sees sales of $945.000 million-$970.000 million vs $1.02 billion analyst estimate.

Oportun Financial Sees FY2025 Adj EPS $1.10-$1.30 vs $1.00 Est; Sees Sales $945.000M-$970.000M vs $1.02B Est

ASPN

Aspen Aerogels shares are trading lower after the company issued Q1 guidance below estimates.

MGM Resorts International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGM#NYSE">MGM</a>) shares are rising in extended trading Wednesday after the company reported better-than-expected financial results for <a href="https://www.benzinga.com/quote/mgm">the fourth quarter</a>.
<ul>
<li>Q4 Revenue: $4.35 billion, versus <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $4.27 billion</li>
</ul>
<ul>
<li>Q4 Adjusted EPS: 45 cents, versus estimates of 30 cents</li>
</ul>
Total revenue was down 1% on a year-over-year basis. Las Vegas Strip revenue came in at $2.2 billion, down 6% year-over-year. Regional revenue totaled $932 million, up 7% year-over-year. MGM China revenue totaled $1 billion, up 4% year-over-year, and MGM digital revenue increased 15% year-over-year to $140 million.
MGM noted that BetMGM accelerated its revenue growth throughout 2024 and is on track to be profitable in 2025. 
The company repurchased approximately 3 million shares during the quarter for approximately $121 million. MGM had $826 million remaining under its buyback as of Dec. 31. The company ended the quarter with $2.42 billion in cash and cash equivalents.
&#8220;MGM Resorts is proud to report the best full-year consolidated net revenues in the history of the company, driven by record performance from MGM China,&#8221; said Bill Hornbuckle, president and CEO of MGM Resorts International.
&#8220;We&#8217;re also encouraged by the strong demand we&#8217;re seeing in the business so far in 2025, which positions us well for continued growth. In fact, December was our highest convention booking month on record, and in January we saw revenue growth in our Las Vegas Strip Resorts and Regional Operations as well as strong future bookings.&#8221;
MGM executives will further discuss the quarter on a call with investors and analysts at 5 p.m. ET.
MGM Price Action: <a href="http://benzinga.com/quote/mgm">MGM shares</a> were up 8% after hours, trading at $37.12 at the time of publication Wednesday, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/sports-betting/25/02/43673996/draftkings-q4-earnings-preview-analyst-says-super-bowl-lix-big-win-for-the-birds-and-the-books">DraftKings Q4 Earnings Preview: Analyst Says Super Bowl LIX = &#8216;Big Win For The Birds And The Books&#8217;</a></li>
</ul>
Photo: Shutterstock.

Global

MGM Resorts International Q4 Earnings: Revenue Beat, EPS Beat, 'Strong Demand' To Start 2025, BetMGM On Track To Turn Profitable This Year

GXO Logistics shares are trading lower. The company reported Q4 financial results.

Oportun Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRT#NASDAQ">OPRT</a>) reported quarterly earnings of $0.49 per share. This is a 190.74 percent increase over losses of $(0.54) per share from the same period last year. The company reported quarterly sales of $250.900 million which beat the analyst consensus estimate of $248.118 million by 1.12 percent. This is a 4.46 percent decrease over sales of $262.600 million the same period last year.

Oportun Financial Q4 2024 Adj. EPS $0.49 Up From $(0.54) YoY, Sales $250.900M Beat $248.118M Estimate

QTWO

Q2 Holdings shares are trading higher after the company reported a year-over-year increase in Q2 financial results,

CRBG

Corebridge Financial shares are trading lower after the company reported Q4 financial results and missed its revenue estimate.

Tronox Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TROX#NYSE">TROX</a>) sees FY2025 sales of $3.000 billion-$3.400 billion vs $3.21 billion analyst estimate.

TROX

Tronox Holdings Sees FY2025 Sales $3.000B-$3.400B vs $3.21B Est

Air T (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRT#NASDAQ">AIRT</a>) reported quarterly losses of $(0.47) per share. This is a 55.66 percent increase over losses of $(1.06) per share from the same period last year. The company reported $77.88 million in sales this quarter. This is a 22.15 percent increase over sales of $63.76 million the same period last year.

AIRT

Air T Q3 EPS $(0.47) Up From $(1.06) YoY, Sales $77.88M Up From $63.76M YoY

TSLA MOVED UP OVER 9 POINTS AT ITS HIGH POINT OF THE DAY
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="796" height="634" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/02/12210715/Screen-Shot-2025-02-12-at-4.12.46-PM.png" alt="" class="wp-image-5733" style="width:920px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/02/12210715/Screen-Shot-2025-02-12-at-4.12.46-PM.png 796w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/02/12210715/Screen-Shot-2025-02-12-at-4.12.46-PM-300x239.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/02/12210715/Screen-Shot-2025-02-12-at-4.12.46-PM-768x612.png 768w" sizes="(max-width: 796px) 100vw, 796px" /></figure>
TESLA, Inc. (TSLA) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions. 
Today, at 10:13 AM on February 12th, a significant trading signal occurred for Tesla, Inc. (TSLA) as it demonstrated a Power Inflow at a price of $334.45. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in Tesla&#8217;s stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in Tesla&#8217;s stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock&#8217;s overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for TSLA, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts. 
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data brought to you by Benzinga APIs</a> and include firms, like&nbsp; &nbsp; <a href="https://www.tradepulse.net">https://www.tradepulse.net</a>&nbsp; which are responsible for parts of the data within this article. 
&#xA9; 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
After Market Close UPDATE:
The price at the time of the Power Inflow was $334.45 The returns on the High price ($346.30) and Close price ($336.53) after the Power Inflow were respectively 3.5% and 0.6%. That is why it is important to have a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite. In this case, the TradePulse data showed a reversal at the point the stock turned down in the last 1/2 hour of trading.
Past Performance is Not Indicative of Future Results

Equities

Technicals

TRADEPULSE POWER INFLOW ALERT: TESLA (TSLA) MOVES 3.5% HIGHER AFTER ALERT FROM TRADEPULSE

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
With the federal government moving to <a href="https://www.forbes.com/sites/dariosabaghi/2024/05/22/dea-publishes-proposed-rules-to-reschedule-marijuana/?sh=57e2057e48e8">reschedule</a> cannabis to Schedule III, effectively paving the way for medical cannabis legalization, <a href="https://investorplace.com/industries/healthcare/cannabis/">cannabis stocks</a> are in the spotlight. Cannabis stocks initially spiked on the news but quickly returned to previous levels. This tempered response reflects concerns about the potential disruption a medical cannabis mandate might bring, creating uncertainty that has made investors hesitant to commit to specific cannabis stocks at this moment. Still, tailwinds are gathering behind small and large cannabis stocks alike, creating a unique opportunity to capture upside as some cannabis stocks approach 52-week lows &mdash; or worse.



Ultimately, these cannabis stocks corner a unique segment in a crowded sector, creating an upside of their own based on fundamental and operational strength. Still, they&rsquo;ve fallen prey to wider uncertainty about cannabis stocks more broadly, even as they buck wider trends that include poor distribution channels, limited marketing opportunities and concerns surrounding banking.



<h2>Tilray&nbsp;(TLRY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/01/shutterstock_1904349628-300x169.png" alt="Closeup of mobile phone screen with logo lettering of cannabinoid company tilray cannabis, blurred marijuana and pipette background"><div>Source: Ralf Liebhold / Shutterstock.com</div></div>Tilray&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/tlry-stock-quote/">TLRY</a>) shares rebounded slightly in recent weeks, but the company&rsquo;s per-share pricing still sits close to 52-week lows and even further from past highs pre-2020 when it traded north of $140. But stock suppression of this magnitude conceals Tilray&rsquo;s true long-term strength compared to other cannabis stocks.



One of those unique strengths is Tilray&rsquo;s expanding craft beer business. Since acquiring several brands from Anheuser-Busch (NYSE:<a href="https://investorplace.com/stock-quotes/bud-stock-quote/">BUD</a>) in 2023, Tilray <a href="https://www.bloomberg.com/news/articles/2024-01-09/craft-beer-growth-is-saving-tilray-from-cannabis-vegetable-woes">doubled its alcohol sales</a>, generating important sales diversification within the competitive cannabis market.



Tilray&rsquo;s craft beer forays are significant and often underestimated. As recreational cannabis legalization progresses through national legislative channels, Tilray&rsquo;s well-established production, distribution, and operational network positions it uniquely to capitalize on eventual legalization. Its newly bought infrastructure could be pivotal in distributing cannabis products nationwide and give Tilray a notable edge over competitors.



Tilray is building a $250 million cash reserve to <a href="https://investorplace.com/2024/06/is-tilray-stock-your-ticket-to-the-coming-u-s-cannabis-gold-rush/">fund strategic acquisitions</a> and expand its operations. While this move will dilute shares, it also creates further unique opportunities among cannabis stocks as Tilray builds and consolidates a US-based empire.



<h2>KindlyMD (KDLY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/04/cannabis-stocks1600-3-300x169.png" alt="scientist checking organic hemp wild plants in a cannabis weed commercial greenhouse. Concept of herbal alternative medicine, cbd oil, pharmaceutical industry. Cannabis stocks, FLGC stocks"><div>Source: Chokniti-Studio / Shutterstock.com</div></div>Including KindlyMD&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/kdly-stock-quote/">KDLY</a>) among cannabis stocks at 52-week lows is kind of cheating, as the company only just hit public markets. Still, shares have slid rapidly since IPO, dropping 22% from its initial $3 listing price. But the rapid downswing, as with Tilray, conceals KindlyMD&rsquo;s unique status amongst cannabis stocks.



KindlyMD is positioned at the intersection of two growing trends: the burgeoning medical cannabis sector and holistic treatments that integrate prescription medication with behavioral, mental therapy, and alternative solutions to &ldquo;<a href="https://kindlymd.com/about-us/">treat the whole person</a>, not just their symptoms.&rdquo;



Although its <a href="https://feeds.issuerdirect.com/news-release.html?newsid=8925359497374292">first earnings report</a> post-IPO showed a modest revenue of $829,000, this is more of a short-term challenge on the path to long-term success. The company has achieved several milestones that indicate significant potential for future growth. Notably, KindlyMD became Utah&rsquo;s first alternative medicine company to secure contracts under the state&rsquo;s insurance programs, including Medicare and Medicaid. It also signed a deal with Blue Cross Blue Shield and currently holds 16% of Utah&rsquo;s medical cannabis market.



<h2>Valley National Bancorp (VLY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/banks1600-300x169.jpg" alt="Image of a grey cityscape with a large corporate building that features the word bank on it"><div>Source: Shutterstock</div></div>As with KindlyMD, Valley National Bancorp&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/vly-stock-quote/">VLY</a>)&nbsp;sits at the intersection of two unique sectors: cannabis and banking. Both sectors are facing unique challenges, though, contributing to Valley National&rsquo;s current per-share pricing woes.



<a href="https://www.morningstar.com/stocks/xnas/vly/quote">Valley National trades</a> at a mere 0.6x book value and 8x earnings, making it both undervalued and often overlooked, considering its unique forays into <a href="https://www.retailbrew.com/series/spliff-and-mortar/stories/2023/03/30/dank-of-america-why-getting-dropped-by-a-bank-is-seen-as-a-rite-of-passage-for-cannabis-retailers">cannabis-based banking</a> as one of the few institutions happily servicing cannabis retailers. The bank&rsquo;s strong financial foundation is evident through its low <a href="https://www.morningstar.com/stocks/xnas/vly/valuation">debt-to-equity ratio</a> of just 0.56, significantly lower than the industry average of 1.2. This demonstrates Valley National&rsquo;s conservative leverage approach compared to its peers. Recent initiatives, such as the <a href="https://finance.yahoo.com/news/valley-national-vly-announces-share-161100413.html">stock buyback program</a> and a 6.07% <a href="https://www.morningstar.com/stocks/xnas/vly/dividends">trailing dividend yield</a>, further highlight the bank&rsquo;s robust financial health and commitment to returning value to shareholders.



<a href="https://equityset.com/stocks/nasdaq-vly?tag=stock-analysis&amp;tab=sentiment">Analysts also see potential</a> in Valley National, setting an average price target of $8.06, which is about 6% above its current share price. Sentiment around the bank stock is improving, with 56% of analysts now recommending a &ldquo;hold,&rdquo; a significant shift from the 50% who advised selling in the previous period. This positive momentum suggests a promising outlook for Valley National as an undervalued investment opportunity among cannabis stocks.



On the date of publication, Jeremy Flint held no positions in the securities mentioned. The opinions expressed in this article are those of the writer, subject to the <a href="http://InvestorPlace.com">InvestorPlace.com</a> <a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;
<div>Jeremy Flint, an MBA graduate and skilled finance writer, excels in content strategy for wealth managers and investment funds. Passionate about simplifying complex market concepts, he focuses on fixed-income investing, alternative investments, economic analysis, and the oil, gas, and utilities sectors. Jeremy&rsquo;s work can also be found at <a href="https://jeremyflint.work/">www.jeremyflint.work</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/07/3-cannabis-stocks-to-buy-at-a-52-week-low-in-july/">3 Cannabis Stocks to Buy at a 52-Week Low in July</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

3 Cannabis Stocks to Buy at a 52-Week Low in July

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Kindly MD (NASDAQ:<a href="https://investorplace.com/stock-quotes/kdly-stock-quote/">KDLY</a>) just reported results for the second quarter of 2024.<ul><li>Kindly MD reported earnings per share of -26 cents.</li><li>The company reported revenue of $639,057.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/kdly-stock-earnings-kindly-md-for-q2-of-2024/">KDLY Stock Earnings: Kindly MD Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

KDLY Stock Earnings: Kindly MD Reported Results for Q2 2024

KindlyMD GAAP EPS of -$0.26

Kindly MD, Inc. (KDLY) has provided an update. Kindly MD, Inc., a Utah-based company, is informing its investors and the broader investment communi...

Kindly MD, Inc. Embraces Social Media for Investor Updates

Kindly MD, Inc. ( ($KDLY) ) just unveiled an announcement. KindlyMD, a healthcare company focusing on integrated medical strategies, has launched a...

Kindly MD, Inc. Announces Stock Repurchase Program

Kindly MD, Inc. ( ($KDLY) ) has provided an announcement. Tim Pickett, CEO of Kindly MD, Inc., is presenting at the LD Micro Conference, sharing in...

Kindly MD CEO Presents at LD Micro Conference

KindlyMD (KDLY) is now contracted with Cigna (CI) Healthcare, after receiving additional credentialing. Cigna's innovative approach to behavioral h...

KindlyMD enters partnership with Cigna Healthcare

Reports Q3 revenue $647,867 vs. $869,268 last year. "We are pleased with the progress made during the third quarter to expand our credentialing and...

KindlyMD reports Q3 EPS (17c) vs. (11c) last year

KindlyMD GAAP EPS of -$0.17, revenue of $0.65M

KindlyMD (KDLY) announced the opening of a new integrated behavioral health clinic location on the campus of Ogden Regional Medical Center, a Mount...

KindlyMD opens health clinic on the Ogden Regional Medical Center Campus

KDLY

TLRY

Press Releases

KindlyMD Announces Second Quarter 2024 Financial Results and Provides Shareholder Update

Management

KindlyMD(TM) Appoints Nancy Pratt as Behavioral Health Program Director

Events

KindlyMD to Participate in H.C. Wainwright's 26th Annual Global Investment Conference on September 9-11, 2024

KindlyMD(TM) Recognized with Healthcare AI Impact Award 2024

KindlyMD(TM) to Participate in Upcoming October Conferences

KindlyMD(TM) Announces Contract with United Healthcare Insurance, the Largest Health Insurer in the United States

KindlyMD(TM) Announces $500,000 Share Repurchase Program

Contracts

KindlyMD(R) Announces New Partnership With Cigna Healthcare to Further Expand Patient Care Accessibility

KindlyMD(R) Announces Third Quarter 2024 Financial Results

KindlyMD(R) Opens New Integrated Behavioral Health Clinic on the Ogden Regional Medical Center Campus

American Shared Hospital Services Common Stock

American Shared Hospital

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International

Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

Enzo Biochem

23andMe Holding

Mobile-health Network Solutions - Class A Ordinary Shares

Mobile-health Network

ModivCare

MSP Recovery, Inc. - Class A Common Stock

MSP Recovery

NewGenIvf Group Limited - Class A Ordinary Shares

NewGenIvf Group

Ontrak

P3 Health Partners Inc. - Class A Common Stock

P3 Health Partners

Prenetics Global Limited - Class A Ordinary Share

Prenetics Global

Precipio

SHL Telemedicine Ltd - American Depositary Shares

Comments

Kindly MD

뉴스

에 대한 최신 뉴스 Kindly MD (NASDAQ:KDLY) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌